MedTrace Logo

Total30 for Astigmatism Contact Lenses

NCT06052046 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2025-02-24

No results posted yet for this study

Summary

Determine if Total30 for Astigmatism contact lenses (CLs) provide a comfortable wearing experience all day. CL discomfort affects most CL wearers with discomfort consistently topping the reasons why established CL wearers drop out of CLs. In fact, studies have consistently found that the frequency of CL dropout is around 20% with this dropout frequency staying relatively stable over the past 20 plus years. This static frequency of CL dropout is surprising since there have been a number of dramatic soft CL innovations during this time frame (e.g., widely available daily disposable CLs, silicone hydrogel CL materials with high oxygen transmissibility, new CL surface coatings).

Conditions

  • Contact Lens Complication
  • Astigmatism
  • Refractive Errors

Interventions

DEVICE

TOTAL30 for Astigmatism Contact Lenses

Participants will be refit into TOTAL30 for Astigmatism Contact Lenses and followed for 1 month.

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Southern College of Optometry

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-15
Primary Completion
2024-05-11
Completion
2024-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06052046 on ClinicalTrials.gov